Sharon Yeatts to Brain Ischemia
This is a "connection" page, showing publications Sharon Yeatts has written about Brain Ischemia.
Connection Strength
1.797
-
Challenges of decision making regarding futility in a randomized trial: the Interventional Management of Stroke III experience. Stroke. 2014 May; 45(5):1408-14.
Score: 0.310
-
National Institutes of Health Stroke Scale as an Outcome in Stroke Research: Value of ANCOVA Over Analyzing Change From Baseline. Stroke. 2022 04; 53(4):e150-e155.
Score: 0.133
-
Predicting 90-Day Outcome After Thrombectomy: Baseline-Adjusted 24-Hour NIHSS Is More Powerful Than NIHSS Score Change. Stroke. 2021 08; 52(8):2547-2553.
Score: 0.127
-
National Institutes of Health Stroke Scale: An Alternative Primary Outcome Measure for Trials of Acute Treatment for Ischemic Stroke. Stroke. 2020 01; 51(1):282-290.
Score: 0.115
-
What Threshold Defines Penumbral Brain Tissue in Patients with Symptomatic Anterior Circulation Intracranial Stenosis: An Exploratory Analysis. J Neuroimaging. 2019 Mar; 29(2):203-205.
Score: 0.107
-
Endovascular Treatment in the DEFUSE 3 Study. Stroke. 2018 08; 49(8):2000-2003.
Score: 0.105
-
Observed Cost and Variations in Short Term Cost-Effectiveness of Therapy for Ischemic Stroke in Interventional Management of Stroke (IMS) III. J Am Heart Assoc. 2017 May 08; 6(5).
Score: 0.096
-
Selection of patients for intra-arterial treatment for acute ischaemic stroke: development and validation of a clinical decision tool in two randomised trials. BMJ. 2017 May 03; 357:j1710.
Score: 0.096
-
A multicenter randomized controlled trial of endovascular therapy following imaging evaluation for ischemic stroke (DEFUSE 3). Int J Stroke. 2017 10; 12(8):896-905.
Score: 0.095
-
ALIAS (Albumin in Acute Ischemic Stroke) Trials: Analysis of the Combined Data From Parts 1 and 2. Stroke. 2016 09; 47(9):2355-9.
Score: 0.091
-
Response. J Neurosurg. 2014 Dec; 121(6):1352-3.
Score: 0.081
-
Early reperfusion and clinical outcomes in patients with M2 occlusion: pooled analysis of the PROACT II, IMS, and IMS II studies. J Neurosurg. 2014 Dec; 121(6):1354-8.
Score: 0.080
-
Complexity of the endovascular intervention and clinical outcomes in acute ischaemic stroke--authors' reply. Lancet Neurol. 2014 Sep; 13(9):865-6.
Score: 0.080
-
Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial. Lancet Neurol. 2014 Jun; 13(6):567-74.
Score: 0.078
-
Alberta Stroke Program early computed tomography score to select patients for endovascular treatment: Interventional Management of Stroke (IMS)-III Trial. Stroke. 2014 Feb; 45(2):444-9.
Score: 0.076
-
Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology. 2009 Sep 29; 73(13):1066-72.
Score: 0.057
-
Effect of Alteplase vs Aspirin on Functional Outcome for Patients With Acute Ischemic Stroke and Minor Nondisabling Neurologic Deficits: The PRISMS Randomized Clinical Trial. JAMA. 2018 07 10; 320(2):156-166.
Score: 0.026
-
Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging. N Engl J Med. 2018 02 22; 378(8):708-718.
Score: 0.025
-
Differential Effect of Baseline Computed Tomographic Angiography Collaterals on Clinical Outcome in Patients Enrolled in the Interventional Management of Stroke III Trial. Stroke. 2015 May; 46(5):1239-44.
Score: 0.021